ReleaseWire Connect

An investigation on behalf of investors, who currently hold shares of Zoltek Companies, Inc. (NASDAQ:ZOLT) shares, was announced concerning whether the takeover of Zoltek Companies, Inc. by Toray Industries, Inc. for $16.75 per share is unfair to NASDAQ:ZOLT stockholders.

An investigation on behalf of investors of Nektar Therapeutics (NASDAQ:NKTR) shares over potential securities laws violations by Nektar Therapeutics and certain of its directors and officers in connection certain financial statements was announced.

An investigation on behalf of investors, who currently hold shares of Eastern Insurance Holdings Inc (NASDAQ:EIHI) shares, was announced concerning whether the takeover of Eastern Insurance Holdings Inc by ProAssurance Corporation for $24.50 per share is unfair to NASDAQ:EIHI stockholders.

An investigation on behalf of investors, who currently hold shares of Flow International Corporation (NASDAQ:FLOW) shares, was announced concerning whether the takeover of Flow International Corporation by American Industrial Partners for $4.05 per NASDAQ:FLOW share is unfair to Flow International stockholders.

An investigation on behalf of investors, who currently hold NASDAQ:STSA shares, is ongoing concerning whether the takeover of Sterling Financial Corporation by Umpqua Holdings Corporation is unfair.

An investigation on behalf of investors, who currently hold NYSE:TPGI shares, is ongoing concerning whether the takeover of Thomas Properties Group, Inc. by Parkway Properties, Inc is unfair.

An investigation on behalf of investors in shares of BioScrip Inc (NASDAQ:BIOS) was announced concerning whether certain BioScrip officers and directors possibly breached their fiduciary duties in connection with certain statements.

An investigation on behalf of investors of J.C. Penney Company, Inc. (NYSE:JCP) shares over potential securities laws violations by J.C. Penney Company and certain of its directors and officers in connection certain financial statements was announced.

An investigation on behalf of investors in shares of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) was announced concerning whether certain AMAG Pharmaceuticals officers and directors possibly breached their fiduciary duties in connection with certain statements.

An investor, who purchased shares of ValueClick Inc (NASDAQ:VCLK), filed a lawsuit in the U.S. District Court for the Central District of California over alleged violations of Federal Securities Laws by ValueClick Inc in connection with certain allegedly false and misleading statements made between February 14, 2013 and August 1, 2013